BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kubotera N, Prokopienko AJ, Garba AO, Pai AB. Endotoxin binding by sevelamer: potential impact on nutritional status. Int J Nephrol 2013;2013:954956. [PMID: 23401772 DOI: 10.1155/2013/954956] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Clauser M, Altenberger J. Adipositas und kardiale Kachexie bei chronischer Herzinsuffizienz. Herz 2013;38:610-7. [DOI: 10.1007/s00059-013-3885-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Ghosh SS, Righi S, Krieg R, Kang L, Carl D, Wang J, Massey HD, Sica DA, Gehr TW, Ghosh S. High Fat High Cholesterol Diet (Western Diet) Aggravates Atherosclerosis, Hyperglycemia and Renal Failure in Nephrectomized LDL Receptor Knockout Mice: Role of Intestine Derived Lipopolysaccharide. PLoS One 2015;10:e0141109. [PMID: 26580567 DOI: 10.1371/journal.pone.0141109] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
3 Rodríguez-Osorio L, Zambrano DP, Gracia-Iguacel C, Rojas-Rivera J, Ortiz A, Egido J, González Parra E. Use of sevelamer in chronic kidney disease: beyond phosphorus control. Nefrologia 2015;35:207-17. [PMID: 26300515 DOI: 10.1016/j.nefro.2015.05.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
4 Basutkar RS, Varghese R, Mathew NK, Sankar Indira P, Viswanathan B, Sivasankaran P. Systematic review and meta-analysis of potential pleiotropic effects of sevelamer in chronic kidney disease: Beyond phosphate control. Nephrology (Carlton) 2021. [PMID: 34882904 DOI: 10.1111/nep.14011] [Reference Citation Analysis]
5 Souza AC, Tsuji T, Baranova IN, Bocharov AV, Wilkins KJ, Street JM, Alvarez-Prats A, Hu X, Eggerman T, Yuen PS, Star RA. TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression. Physiol Rep 2015;3:e12558. [PMID: 26416975 DOI: 10.14814/phy2.12558] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
6 Wu CL, Wu HM, Chiu PF, Liou HH, Chang CB, Tarng DC, Chang CC. Associations between the duration of dialysis, endotoxemia, monocyte chemoattractant protein-1, and the effects of a short-dwell exchange in patients requiring continuous ambulatory peritoneal dialysis. PLoS One 2014;9:e109558. [PMID: 25286027 DOI: 10.1371/journal.pone.0109558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
7 Ibrahim M, Behairy M, El-Ashry M, Mostafa AE. Cardiovascular risk of circulating endotoxin level in prevalent hemodialysis patients. Egypt Heart J 2018;70:27-33. [PMID: 29622994 DOI: 10.1016/j.ehj.2017.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
8 Díaz-De la Cruz EN, Cerrillos-Gutiérrez JI, García-Sánchez A, Prado-Nevárez CG, Andrade-Sierra J, Jalomo-Martínez B, Banda-López A, Rojas-Campos E, Miranda-Díaz AG. The Influence of Sevelamer Hydrochloride and Calcium Carbonate on Markers of Inflammation and Oxidative Stress in Hemodialysis at Six Months of Follow-Up. Front Med (Lausanne) 2021;8:714205. [PMID: 34901050 DOI: 10.3389/fmed.2021.714205] [Reference Citation Analysis]